Response to “Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real‐World Data”

Autor Müntze, Jonas, Nordbeck, Peter
Vydáno v Clin Pharmacol Ther (2019)

Long‐term outcome after surgical repair of a rapid‐grown ischemic ventricular aneurysm causing ventricular tachycardia

Autor Gensler, Daniel, Müntze, Jonas, Nordbeck, Peter
Vydáno v Clin Case Rep (2019)

Contemporary therapeutics and new drug developments for treatment of Fabry disease: a narrative review

Autor Oder, Daniel, Müntze, Jonas, Nordbeck, Peter
Vydáno v Cardiovasc Diagn Ther (2021)

Treatment of hypertrophic cardiomyopathy caused by cardiospecific variants of Fabry disease with chaperone therapy

Autor Müntze, Jonas, Salinger, Tim, Gensler, Daniel, Wanner, Christoph, Nordbeck, Peter
Vydáno v Eur Heart J (2018)

Hot topics in Fabry disease

Autor Cairns, Tereza, Müntze, Jonas, Gernert, Judith, Spingler, Lisa, Nordbeck, Peter, Wanner, Christoph
Vydáno v Postgrad Med J (2018)

Impella CP use in patients with non‐ischaemic cardiogenic shock

Autor Maniuc, Octavian, Salinger, Tim, Anders, Fabian, Müntze, Jonas, Liu, Dan, Hu, Kai, Ertl, Georg, Frantz, Stefan, Nordbeck, Peter
Vydáno v ESC Heart Fail (2019)

Cardiac and renal dysfunction is associated with progressive hearing loss in patients with Fabry disease

Autor Köping, Maria, Shehata-Dieler, Wafaa, Cebulla, Mario, Rak, Kristen, Oder, Daniel, Müntze, Jonas, Nordbeck, Peter, Wanner, Christoph, Hagen, Rudolf, Schraven, Sebastian
Vydáno v PLoS One (2017)

Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 Year

Autor Müntze, Jonas, Gensler, Daniel, Maniuc, Octavian, Liu, Dan, Cairns, Tereza, Oder, Daniel, Hu, Kai, Lorenz, Kristina, Frantz, Stefan, Wanner, Christoph, Nordbeck, Peter
Vydáno v Clin Pharmacol Ther (2019)

Association and diagnostic utility of diastolic dysfunction and myocardial fibrosis in patients with Fabry disease

Autor Liu, Dan, Oder, Daniel, Salinger, Tim, Hu, Kai, Müntze, Jonas, Weidemann, Frank, Herrmann, Sebastian, Ertl, Georg, Wanner, Christoph, Frantz, Stefan, Störk, Stefan, Nordbeck, Peter
Vydáno v Open Heart (2018)

Clinical impact of the alpha-galactosidase A gene single nucleotide polymorphism -10C>T: A single-center observational study

Autor Oder, Daniel, Liu, Dan, Üçeyler, Nurcan, Sommer, Claudia, Hu, Kai, Salinger, Tim, Müntze, Jonas, Petritsch, Bernhard, Ertl, Georg, Wanner, Christoph, Nordbeck, Peter, Weidemann, Frank
Vydáno v Medicine (Baltimore) (2018)

Value of the CHA(2)DS(2)-VASc score and Fabry-specific score for predicting new-onset or recurrent stroke/TIA in Fabry disease patients without atrial fibrillation

Autor Liu, Dan, Hu, Kai, Schmidt, Marie, Müntze, Jonas, Maniuc, Octavian, Gensler, Daniel, Oder, Daniel, Salinger, Tim, Weidemann, Frank, Ertl, Georg, Frantz, Stefan, Wanner, Christoph, Nordbeck, Peter
Vydáno v Clin Res Cardiol (2018)

Association between Comorbidities and Progression of Transvalvular Pressure Gradients in Patients with Moderate and Severe Aortic Valve Stenosis

Autor Salinger, Tim, Hu, Kai, Liu, Dan, Taleh, Scharoch, Herrmann, Sebastian, Oder, Daniel, Gensler, Daniel, Müntze, Jonas, Ertl, Georg, Lorenz, Kristina, Frantz, Stefan, Weidemann, Frank, Nordbeck, Peter
Vydáno v Cardiol Res Pract (2018)